This company has shut down. Clairvoyant Therapeutics is no longer operating.
Explore the Startup GraveyardClairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.
Clairvoyant Therapeutics's investors include Negev Capital, Origin Therapeutics.
Clairvoyant Therapeutics is headquartered in Vancouver, Canada.
Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.
Clairvoyant Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clairvoyant Therapeutics — Funding & Investors." VCBacked, July 7, 2022, https://www.vcbacked.co/company/clairvoyant-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Clairvoyant Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/clairvoyant-therapeutics
{{cite web |title=Clairvoyant Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/clairvoyant-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated